Skip to content

Adverse Reactions to Biologics

276505.jpg
Shelley Hwang has just received a copy of the book Adverse Reactions to Biologics that includes her chapter on the monoclonal antibodies used in Melanoma patients: ipilimumab, nivolumab and pembrolizumab. Shelley is one of the CTSR experts in the cutaneous effects of checkpoint inhibitors used in patients with cancers.

Last Updated on 6 December 2017 by Prof Fernandez-Peñas